{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T06:24:51Z","timestamp":1792823091960,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T00:00:00Z","timestamp":1722902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T00:00:00Z","timestamp":1722902400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP19H03178"],"award-info":[{"award-number":["JP19H03178"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP24H00058"],"award-info":[{"award-number":["JP24H00058"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP19H05643"],"award-info":[{"award-number":["JP19H05643"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP26000013"],"award-info":[{"award-number":["JP26000013"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008664","name":"Ono Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008664","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Thyroid hormones (TH) regulate the basal metabolic rate through their receptors THR\u03b1 and THR\u03b2. TH activates lipid metabolism via THR\u03b2, however, an excess amount of TH can lead to tachycardia, bone loss, and muscle wasting through THR\u03b1. In recent years, TH analogs that selectively bind to THR\u03b2 have gained attention as new agents for treating dyslipidemia and obesity, which continue to pose major challenges to public health worldwide.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We developed a TH analog, ZTA-261, by modifying the existing THR\u03b2-selective agonists GC-1 and GC-24. To determine the THR\u03b2-selectivity of ZTA-261, an in vitro radiolabeled TH displacement assay was conducted. ZTA-261 was intraperitoneally injected into a mouse model of high-fat diet-induced obesity, and its effectiveness in reducing body weight and visceral fat, and improving lipid metabolism was assessed. In addition, its toxicity in the liver, heart, and bone was evaluated.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>ZTA-261 is more selective towards THR\u03b2 than GC-1. Although ZTA-261 is less effective in reducing body weight and visceral fat than GC-1, it is as effective as GC-1 in reducing the levels of serum and liver lipids. These effects are mediated by the same pathway as that of T<jats:sub>3<\/jats:sub>, a natural TH, as evidenced by similar changes in the expression of TH-induced and lipid metabolism-related genes. The bone, cardiac, and hepatotoxicity of ZTA-261 are significantly lower than those of GC-1.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>ZTA-261, a highly selective and less toxic THR\u03b2 agonist, has the potential to be used as a drug for treating diseases related to lipid metabolism.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1038\/s43856-024-00574-z","type":"journal-article","created":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T10:04:25Z","timestamp":1722938665000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Synthesis and preclinical testing of a selective beta-subtype agonist of thyroid hormone receptor ZTA-261"],"prefix":"10.1038","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0153-3178","authenticated-orcid":false,"given":"Masakazu","family":"Nambo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1324-6651","authenticated-orcid":false,"given":"Taeko","family":"Nishiwaki-Ohkawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary T.","family":"Ariki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuuki","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Yar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0428-6590","authenticated-orcid":false,"given":"Jacky C. -H.","family":"Yim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5748-944X","authenticated-orcid":false,"given":"Emily","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Sharkey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8535-9674","authenticated-orcid":false,"given":"Keiko","family":"Kano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5528-4440","authenticated-orcid":false,"given":"Emi","family":"Mishiro-Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosuke","family":"Okimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8821-5756","authenticated-orcid":false,"given":"Michiyo","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4478-5471","authenticated-orcid":false,"given":"Wataru","family":"Ota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4175-3167","authenticated-orcid":false,"given":"Tomoya","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misato","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumihiko","family":"Horio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9991-9118","authenticated-orcid":false,"given":"Ayato","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2154-8107","authenticated-orcid":false,"given":"Cathleen M.","family":"Crudden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7018-9652","authenticated-orcid":false,"given":"Takashi","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,6]]},"reference":[{"key":"574_CR1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1056\/NEJMoa1614362","volume":"377","author":"The GBD 2015 Obesity Collaborators.","year":"2017","unstructured":"The GBD 2015 Obesity Collaborators. Health effects of overweight and obesity in 195 countries over 25 years. N. Engl. J. Med. 377, 13\u201327 (2017).","journal-title":"N. Engl. J. Med."},{"key":"574_CR2","doi-asserted-by":"publisher","first-page":"e65174","DOI":"10.1371\/journal.pone.0065174","volume":"30","author":"GM Singh","year":"2013","unstructured":"Singh, G. M. et al. The age-specific quantitative effects of metabolic risk factors on cardiovascular diseases and diabetes: a pooled analysis. PLoS ONE 30, e65174 (2013).","journal-title":"PLoS ONE"},{"key":"574_CR3","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1111\/j.1467-789X.2011.00879.x","volume":"12","author":"S Czernichow","year":"2011","unstructured":"Czernichow, S., Kengne, A. P., Stamatakis, E., Hamer, M. & Batty, G. D. Body mass index, waist circumference and waist-hip ratio: which is the better discriminator of cardiovascular disease mortality risk?: evidence from an individual-participant meta-analysis of 82,864 participants from nine cohort studies. Obes. Rev. 12, 680\u2013687 (2011).","journal-title":"Obes. Rev."},{"key":"574_CR4","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1056\/NEJMsr1606602","volume":"375","author":"B Lauby-Secretan","year":"2017","unstructured":"Lauby-Secretan, B. et al. Body fatness and cancer\u2014viewpoint of the IARC Working Group. N. Engl. J. Med. 375, 794\u2013798 (2017).","journal-title":"N. Engl. J. Med."},{"key":"574_CR5","unstructured":"Feingold, K. R. Cholesterol lowering drugs. In Endotext (eds Feingold, K. R. et al.) (MDText.com, Inc., 2021)."},{"key":"574_CR6","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0014-2999(02)01420-6","volume":"440","author":"M Krotkiewski","year":"2002","unstructured":"Krotkiewski, M. Thyroid hormones in the pathogenesis and treatment of obesity. Eur. J. Pharmacol. 440, 85\u201398 (2002).","journal-title":"Eur. J. Pharmacol."},{"key":"574_CR7","doi-asserted-by":"publisher","first-page":"7606","DOI":"10.1002\/anie.201601116","volume":"55","author":"S Mondal","year":"2016","unstructured":"Mondal, S., Raja, K., Schweizer, U. & Mugesh, G. Chemistry and biology in the biosynthesis and action of thyroid hormones. Angew. Chem. Int. Ed. Engl. 55, 7606\u20137630 (2016).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"574_CR8","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1530\/JOE-10-0481","volume":"209","author":"AL Maia","year":"2011","unstructured":"Maia, A. L., Goemann, I. M., Meyer, E. L. & Wajner, S. M. Deiodinases: the balance of thyroid hormone: type 1 iodothyronine deiodinase in human physiology and disease. J. Endocrinol. 209, 283\u2013297 (2011).","journal-title":"J. Endocrinol."},{"key":"574_CR9","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1172\/JCI60047","volume":"122","author":"GA Brent","year":"2012","unstructured":"Brent, G. A. Mechanisms of thyroid hormone action. J. Clin. Investig. 122, 3035\u20133043 (2012).","journal-title":"J. Clin. Investig."},{"key":"574_CR10","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.cell.2006.06.049","volume":"126","author":"AL Bookout","year":"2006","unstructured":"Bookout, A. L. et al. Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network. Cell 126, 789\u2013799 (2006).","journal-title":"Cell"},{"key":"574_CR11","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1111\/j.1749-6632.1995.tb24843.x","volume":"758","author":"RC Ribeiro","year":"1995","unstructured":"Ribeiro, R. C. et al. The molecular biology of thyroid hormone action. Ann. N.Y. Acad. Sci. 758, 366\u2013389 (1995).","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"574_CR12","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1080\/03007995.2017.1330259","volume":"33","author":"AP Delitala","year":"2017","unstructured":"Delitala, A. P., Delitala, G., Sioni, P. & Fanciulli, G. Thyroid hormone analogs for the treatment of dyslipidemia: past, present, and future. Curr. Med. Res. Opin. 33, 1985\u20131993 (2017).","journal-title":"Curr. Med. Res. Opin."},{"key":"574_CR13","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1089\/thy.2020.0071","volume":"30","author":"R Zucchi","year":"2020","unstructured":"Zucchi, R. Thyroid hormone analogues: an update. Thyroid 30, 1099\u20131105 (2020).","journal-title":"Thyroid"},{"key":"574_CR14","doi-asserted-by":"publisher","first-page":"5649","DOI":"10.1021\/jm2004706","volume":"55","author":"AA Joharapurkar","year":"2012","unstructured":"Joharapurkar, A. A., Dhote, V. V. & Jain, M. R. Selective thyromimetics using receptor and tissue selectivity approaches: prospects for dyslipidemia. J. Med. Chem. 55, 5649\u20135675 (2012).","journal-title":"J. Med. Chem."},{"key":"574_CR15","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S1074-5521(98)90168-5","volume":"5","author":"G Chiellini","year":"1998","unstructured":"Chiellini, G. et al. A high-affinity subtype-selective agonist ligand for the thyroid hormone receptor. Chem. Biol. 5, 299\u2013306 (1998).","journal-title":"Chem. Biol."},{"key":"574_CR16","doi-asserted-by":"publisher","first-page":"15358","DOI":"10.1073\/pnas.2136689100","volume":"100","author":"S Borngraeber","year":"2003","unstructured":"Borngraeber, S. et al. Ligand selectivity by seeking hydrophobicity in thyroid hormone receptor. Proc. Natl Acad. Sci. USA 100, 15358\u201315363 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"574_CR17","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1021\/acscatal.6b03434","volume":"7","author":"M Nambo","year":"2017","unstructured":"Nambo, M., Keske, E. C., Rygus, J. P. G., Yim, J. C.-H. & Crudden, C. M. Development of versatile sulfone electrophiles for Suzuki\u2013Miyaura cross-coupling reactions. ACS Catal. 7, 1108\u20131112 (2017).","journal-title":"ACS Catal."},{"key":"574_CR18","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.vascn.2006.12.003","volume":"56","author":"J Chapo","year":"2007","unstructured":"Chapo, J., Peng, Y. & Pitts, K. R. A phosphorimager-based filter binding thyroid hormone receptor competition assay for chemical screening. J. Pharmacol. Toxicol. Methods 56, 28\u201333 (2007).","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"574_CR19","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","volume":"226","author":"J Forch","year":"1957","unstructured":"Forch, J., Lees, M. & Sloane Stanley, G. H. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226, 497\u2013509 (1957).","journal-title":"J. Biol. Chem."},{"key":"574_CR20","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s10142-023-01055-7","volume":"23","author":"F Xie","year":"2023","unstructured":"Xie, F., Wang, J. & Zhang, B. RefFinder: a web-based tool for comprehensively analyzing and identifying reference genes. Funct. Integr. Genom. 23, 125 (2023).","journal-title":"Funct. Integr. Genom."},{"key":"574_CR21","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s11103-012-9885-2","volume":"80","author":"F Xie","year":"2012","unstructured":"Xie, F. et al. miRDeepFinder: a miRNA analysis tool for deep sequencing of plant small RNAs. Plant Mol. Biol. 80, 75\u201384 (2012).","journal-title":"Plant Mol. Biol."},{"key":"574_CR22","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","volume":"29","author":"MW Pfaffl","year":"2001","unstructured":"Pfaffl, M. W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29, e45 (2001).","journal-title":"Nucleic Acids Res."},{"key":"574_CR23","doi-asserted-by":"publisher","first-page":"H587","DOI":"10.1152\/ajpheart.00588.2015","volume":"310","author":"A Ol\u00e1h","year":"2016","unstructured":"Ol\u00e1h, A. et al. Physiological and pathological left ventricular hypertrophy of comparable degree is associated with characteristic differences of in vivo hemodynamics. Am. J. Physiol. Heart. Circ. Physiol. 310, H587\u2013H597 (2016).","journal-title":"Am. J. Physiol. Heart. Circ. Physiol."},{"key":"574_CR24","doi-asserted-by":"publisher","first-page":"6417","DOI":"10.1016\/S0021-9258(19)41080-6","volume":"250","author":"D Koerner","year":"1975","unstructured":"Koerner, D., Schwartz, H. L., Surks, M. I. & Oppenheimer, J. H. Binding of selected iodothyronine analogues to receptor sites of isolated rat hepatic nuclei. High correlation between structural requirements for nuclear binding and biological activity. J. Biol. Chem. 250, 6417\u20136423 (1975).","journal-title":"J. Biol. Chem."},{"key":"574_CR25","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1021\/jm00217a001","volume":"20","author":"SW Dietrich","year":"1977","unstructured":"Dietrich, S. W., Bolger, M. B., Kollman, P. A. & Jorgensen, E. C. Thyroxine analogues. 23. Quantitative structure-activity correlation studies of in vivo and in vitro thyromimetic activities. J. Med. Chem. 20, 863\u2013880 (1977).","journal-title":"J. Med. Chem."},{"key":"574_CR26","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1248\/cpb.44.1273","volume":"44","author":"K Sagi","year":"1996","unstructured":"Sagi, K., Kagechika, H., Fukasawa, H., Hashimoto, Y. & Shudo, K. Deiodotrifluoromethylation of ethyl 3,3\u2019,5-triiodothyroacetate. divergent derivatization based on the combinatorial concept. Chem. Pharm. Bull. 44, 1273\u20131275 (1996).","journal-title":"Chem. Pharm. Bull."},{"key":"574_CR27","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1039\/C0OB00843E","volume":"9","author":"Y Nakamura","year":"2011","unstructured":"Nakamura, Y. et al. Click-made\u201d biaryl-linker improving efficiency in protein labelling for the membrane target protein of a bioactive compound. Org. Biomol. Chem. 9, 83\u201385 (2011).","journal-title":"Org. Biomol. Chem."},{"key":"574_CR28","doi-asserted-by":"publisher","first-page":"10297","DOI":"10.1073\/pnas.0504379102","volume":"102","author":"L Johansson","year":"2005","unstructured":"Johansson, L. et al. Selective thyroid receptor modulation by GC-1 reduces serum lipids and stimulates steps of reverse cholesterol transport in euthyroid mice. Proc. Natl Acad. Sci. USA 102, 10297\u201310302 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"574_CR29","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.semcdb.2020.04.011","volume":"108","author":"F Seebacher","year":"2020","unstructured":"Seebacher, F., Zeigerer, A., Kory, N. & Krahmer, N. Hepatic lipid droplet homeostasis and fatty liver disease. Semin. Cell Dev. Biol. 108, 72\u201381 (2020).","journal-title":"Semin. Cell Dev. Biol."},{"key":"574_CR30","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1517\/14728222.2016.1090429","volume":"20","author":"LJ Lammel","year":"2016","unstructured":"Lammel, L. J. & Webb, P. Sobetirome: the past, present and questions about the future. Expert Opin. Ther. Targets 20, 145\u2013149 (2016).","journal-title":"Expert Opin. Ther. Targets"},{"key":"574_CR31","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3390\/biom12010057","volume":"12","author":"T Li","year":"2021","unstructured":"Li, T., Guo, W. & Zhou, Z. Adipose triglyceride lipase in hepatic physiology and pathophysiology. Biomolecules 12, 57 (2021).","journal-title":"Biomolecules"},{"key":"574_CR32","doi-asserted-by":"publisher","first-page":"832","DOI":"10.7326\/0003-4819-148-11-200806030-00225","volume":"148","author":"N Ochs","year":"2008","unstructured":"Ochs, N. et al. Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality. Ann. Intern. Med. 148, 832\u2013845 (2008).","journal-title":"Ann. Intern. Med."},{"key":"574_CR33","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1677\/JME-09-0067","volume":"44","author":"L Calz\u00e0","year":"2010","unstructured":"Calz\u00e0, L., Fernandez, M. & Giardino, L. Cellular approaches to central nervous system remyelination stimulation: thyroid hormone to promote myelin repair via endogenous stem and precursor cells. J. Mol. Endocrinol. 44, 13\u201323 (2010).","journal-title":"J. Mol. Endocrinol."},{"key":"574_CR34","doi-asserted-by":"publisher","first-page":"5842","DOI":"10.1016\/j.bmc.2016.09.038","volume":"24","author":"AT Placzek","year":"2016","unstructured":"Placzek, A. T. et al. Sobetirome prodrug esters with enhanced blood-brain barrier permeability. Bioorg. Med. Chem. 24, 5842\u20135854 (2016).","journal-title":"Bioorg. Med. Chem."},{"key":"574_CR35","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.neuint.2008.12.002","volume":"54","author":"S Nakagawa","year":"2009","unstructured":"Nakagawa, S. et al. A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes. Neurochem. Int. 54, 253\u2013263 (2009).","journal-title":"Neurochem. Int."},{"key":"574_CR36","doi-asserted-by":"publisher","first-page":"7193","DOI":"10.1021\/acs.jmedchem.2c00144","volume":"65","author":"Q Li","year":"2022","unstructured":"Li, Q. et al. Discovery of a highly selective and H435R-sensitive thyroid hormone receptor \u03b2 agonist. J. Med. Chem. 65, 7193\u20137211 (2022).","journal-title":"J. Med. Chem."},{"key":"574_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2019.112006","volume":"188","author":"M Runfola","year":"2020","unstructured":"Runfola, M. et al. Design, synthesis and biological evaluation of novel TR\u03b2 selective agonists sustained by ADME-toxicity analysis. Eur. J. Med. Chem. 188, 112006 (2020).","journal-title":"Eur. J. Med. Chem."},{"key":"574_CR38","doi-asserted-by":"publisher","first-page":"3284","DOI":"10.1021\/acs.jmedchem.2c01669","volume":"66","author":"L Hu","year":"2023","unstructured":"Hu, L. et al. Discovery of highly potent and selective thyroid hormone receptor \u03b2 agonists for the treatment of nonalcoholic steatohepatitis. J. Med. Chem. 66, 3284\u20133300 (2023).","journal-title":"J. Med. Chem."},{"key":"574_CR39","doi-asserted-by":"publisher","first-page":"2919","DOI":"10.1038\/s41591-023-02603-1","volume":"29","author":"SA Harrison","year":"2023","unstructured":"Harrison, S. A. et al. Resmetirom for nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled phase 3 trial. Nat. Med. 29, 2919\u20132928 (2023).","journal-title":"Nat. Med."},{"key":"574_CR40","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1210\/en.2011-1325","volume":"153","author":"C Yuan","year":"2012","unstructured":"Yuan, C. et al. Identical gene regulation patterns of T3 and selective thyroid hormone receptor modulator GC-1. Endocrinology 153, 501\u2013511 (2012).","journal-title":"Endocrinology"},{"key":"574_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0240338","volume":"15","author":"XG Luong","year":"2020","unstructured":"Luong, X. G. et al. Regulation of gene transcription by thyroid hormone receptor \u03b2 agonists in clinical development for the treatment of non-alcoholic steatohepatitis (NASH). PLoS ONE 15, e02403382020 (2020).","journal-title":"PLoS ONE"},{"key":"574_CR42","doi-asserted-by":"publisher","first-page":"6136","DOI":"10.1210\/en.2011-2081","volume":"153","author":"JZ Lin","year":"2012","unstructured":"Lin, J. Z. et al. Thyroid hormone receptor agonists reduce serum cholesterol independent of the LDL receptor. Endocrinology 153, 6136\u20136144 (2012).","journal-title":"Endocrinology"},{"key":"574_CR43","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.atherosclerosis.2014.09.035","volume":"237","author":"K Kannisto","year":"2014","unstructured":"Kannisto, K. et al. The thyroid receptor \u03b2 modulator GC-1 reduces atherosclerosis in ApoE deficient mice. Atherosclerosis 237, 544\u2013554 (2014).","journal-title":"Atherosclerosis"},{"key":"574_CR44","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.tem.2009.11.004","volume":"21","author":"YY Liu","year":"2010","unstructured":"Liu, Y. Y. & Brent, G. A. Thyroid hormone crosstalk with nuclear receptor signaling in metabolic regulation. Trends Endocrinol. Metab. 21, 166\u2013173 (2010).","journal-title":"Trends Endocrinol. Metab."},{"key":"574_CR45","doi-asserted-by":"publisher","first-page":"5143","DOI":"10.1210\/en.2012-1572","volume":"153","author":"IJ Goldberg","year":"2012","unstructured":"Goldberg, I. J. et al. Thyroid hormone reduces cholesterol via a non-LDL receptor-mediated pathway. Endocrinology 153, 5143\u20135149 (2012).","journal-title":"Endocrinology"},{"key":"574_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-33977-4","volume":"13","author":"N Imai","year":"2023","unstructured":"Imai, N. et al. Distinct features of two lipid droplets types in cell nuclei from patients with liver diseases. Sci. Rep. 13, 6851 (2023).","journal-title":"Sci. Rep."},{"key":"574_CR47","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1056\/NEJM200102153440707","volume":"344","author":"I Klein","year":"2001","unstructured":"Klein, I. & Ojamaa, K. Thyroid hormone and the cardiovascular system. N. Engl. J. Med. 344, 501\u2013509 (2001).","journal-title":"N. Engl. J. Med."},{"key":"574_CR48","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s001980070062","volume":"11","author":"P Tannirandorn","year":"2000","unstructured":"Tannirandorn, P. & Epstein, S. Drug-induced bone loss. Osteoporos. Int. 11, 637\u2013659 (2000).","journal-title":"Osteoporos. Int."},{"key":"574_CR49","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.bbadis.2018.08.037","volume":"1865","author":"MR McGill","year":"2019","unstructured":"McGill, M. R. & Jaeschke, H. Animal models of drug-induced liver injury. Biochim. Biophys. Acta Mol. Basis Dis. 1865, 1031\u20131039 (2019).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."}],"container-title":["Communications Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43856-024-00574-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-024-00574-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-024-00574-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T10:15:34Z","timestamp":1722939334000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43856-024-00574-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,6]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["574"],"URL":"https:\/\/doi.org\/10.1038\/s43856-024-00574-z","relation":{},"ISSN":["2730-664X"],"issn-type":[{"value":"2730-664X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,6]]},"assertion":[{"value":"21 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"152"}}